Results 171 to 180 of about 12,789 (247)

Case Report: HER2-positive vulvar Paget disease achieving long-term control with trastuzumab-based systemic therapy plus radiotherapy. [PDF]

Front Med (Lausanne)
Xie X, Chen Q, Zhang J, Peng X.
europepmc   +1 more source

Assessing the burden of HPV-associated cancers in Brazil: Hospitalization and mortality trends from 2011 to 2019. [PDF]

Hum Vaccin Immunother
Parellada CI, Bierrenbach AL, Bittencourt Campaner A, Gonçalves Queijo R, Rocha Sarmento TT, Orengo JC.   +5 more
europepmc   +1 more source

[100 cases of malignant vulvar neoplasms].

Ginekologia polska, 1974
A, Miecznikowski, W, Medvey, M, Maczka
openaire   +1 more source

Rising U.S. trends in HPV-positive and HPV-negative vulvar cancer in older adults, 2000-2020. [PDF]

Gynecol Oncol Rep
Mata Zetina AP, Rajupet S, Strange T, Davidov A, Dhar M, Dhulipalla L, Gut T, Scarbrough KH, Castellanos MR.   +8 more
europepmc   +1 more source

Breast Metastasis From Vulvar Carcinoma: Case Report and Review of Literature. [PDF]

Case Rep Obstet Gynecol
Khessairi N, Sakhri S, Chrigui M, Krimi O, Bouaziz H, Dhiab TB.   +5 more
europepmc   +1 more source

Liquid Biopsy Analysis of the EV-Associated Micro-RNA Signature in Vulvar Carcinoma May Benefit Disease Diagnosis and Prognosis. [PDF]

Cancers (Basel)
Borchardt F, Kleinholz L, Jaeger A, Löptien J, Vohl V, Kropidlowski J, Pantel K, Vettorazzi E, Woelber L, Wikman H, Effenberger K.   +10 more
europepmc   +1 more source

Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma. [PDF]

Arch Gynecol Obstet
Grischke EM, Neis F, Oberlechner E, Henes M, Weiß M, Brucker SY.   +5 more
europepmc   +1 more source

Angiomyofibroblastoma of the vulva in a 29-year-old woman: a case report of a rare entity with successful vaginal delivery. [PDF]

BMC Pregnancy Childbirth
Chen H, Wang L, Xie D, Lin X, Chen D, Zhao J.   +5 more
europepmc   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial. [PDF]

Int J Cancer
Stankiewicz Karita HC, Magaret AS, Doody DR, Schouten JT, Mao C, Huh WK, Grieco VS, Seymour MA, Varon D, Shrader KH, Xi LF, Galloway DA, Wald A, Madeleine MM.   +13 more
europepmc   +1 more source